This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Novartis Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Michael Kiffe: Innovator in Bispecific Antibodies
Introduction
Michael Kiffe is a notable inventor based in Efringen-Kirchen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work focuses on innovative treatments for specific inflammasomopathies, showcasing his commitment to advancing medical science.
Latest Patents
Michael Kiffe holds a patent for bispecific antibodies designed for the treatment of NLRC4-GOF inflammasomapathy. This invention involves bivalent bispecific monoclonal antibodies (bbmAb) or their variants, aimed at alleviating symptoms associated with NLRC4 inflammasomopathy. The patent highlights the potential of these antibodies in providing therapeutic benefits to subjects in need.
Career Highlights
Throughout his career, Michael Kiffe has been associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical research and innovation.
Collaborations
Michael has worked alongside notable colleagues such as Guido Junge and Jiri Kovarik. These collaborations have played a crucial role in the development of his innovative solutions in the realm of bispecific antibodies.
Conclusion
Michael Kiffe's work in the field of bispecific antibodies represents a significant advancement in the treatment of inflammasomopathies. His dedication to innovation and collaboration continues to impact the medical community positively.